These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11413180)

  • 1. Results from a family and DNA based active identification programme for familial hypercholesterolaemia.
    ten Asbroek AH; de Mheen PJ; Defesche JC; Kastelein JJ; Gunning-Schepers LJ
    J Epidemiol Community Health; 2001 Jul; 55(7):500-2. PubMed ID: 11413180
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (FH) and Familial defective apolipoprotein B100 (FDB).
    Azian M; Hapizah MN; Khalid BA; Khalid Y; Rosli A; Jamal R
    Malays J Pathol; 2006 Jun; 28(1):7-15. PubMed ID: 17694954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales.
    Haralambos K; Whatley SD; Edwards R; Gingell R; Townsend D; Ashfield-Watt P; Lansberg P; Datta DB; McDowell IF
    Atherosclerosis; 2015 May; 240(1):190-6. PubMed ID: 25797312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic screening for familial hypercholesterolaemia in Hong Kong.
    Tan K; Cheung CL; Yeung CY; Siu D; Leung J; Pang HK
    Hong Kong Med J; 2018 Jun; 24 Suppl 3(3):7-10. PubMed ID: 29937437
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular testing for familial hypercholesterolaemia-associated mutations in a UK-based cohort: development of an NGS-based method and comparison with multiplex polymerase chain reaction and oligonucleotide arrays.
    Reiman A; Pandey S; Lloyd KL; Dyer N; Khan M; Crockard M; Latten MJ; Watson TL; Cree IA; Grammatopoulos DK
    Ann Clin Biochem; 2016 Nov; 53(6):654-662. PubMed ID: 26748104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parental attitude towards genetic testing for familial hypercholesterolaemia in children.
    Umans-Eckenhausen MA; Oort FJ; Ferenschild KC; Defesche JC; Kastelein JJ; de Haes JC
    J Med Genet; 2002 Sep; 39(9):e49. PubMed ID: 12205119
    [No Abstract]   [Full Text] [Related]  

  • 7. Spectrum of LDLR gene mutations, including a novel mutation causing familial hypercholesterolaemia, in North-western Greece.
    Diakou M; Miltiadous G; Xenophontos SL; Manoli P; Cariolou MA; Elisaf M
    Eur J Intern Med; 2011 Oct; 22(5):e55-9. PubMed ID: 21925044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic screening of patients with familial hypercholesterolaemia (FH): a New Zealand perspective.
    Laurie AD; Scott RS; George PM
    Atheroscler Suppl; 2004 Dec; 5(5):13-5. PubMed ID: 15556094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic analysis of familial hypercholesterolaemia in Western Australia.
    Hooper AJ; Nguyen LT; Burnett JR; Bates TR; Bell DA; Redgrave TG; Watts GF; van Bockxmeer FM
    Atherosclerosis; 2012 Oct; 224(2):430-4. PubMed ID: 22883975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular epidemiology of familial hypercholesterolaemia.
    Defesche JC; Kastelein JJ
    Lancet; 1998 Nov; 352(9141):1643-4. PubMed ID: 9853432
    [No Abstract]   [Full Text] [Related]  

  • 11. Mutation screening in patients for familial hypercholesterolaemia (ADH).
    Taylor A; Patel K; Tsedeke J; Humphries SE; Norbury G
    Clin Genet; 2010 Jan; 77(1):97-9. PubMed ID: 19843101
    [No Abstract]   [Full Text] [Related]  

  • 12. Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands.
    Umans-Eckenhausen MA; Defesche JC; Sijbrands EJ; Scheerder RL; Kastelein JJ
    Lancet; 2001 Jan; 357(9251):165-8. PubMed ID: 11213091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial hypercholesterolaemia: A global call to arms.
    Vallejo-Vaz AJ; Kondapally Seshasai SR; Cole D; Hovingh GK; Kastelein JJ; Mata P; Raal FJ; Santos RD; Soran H; Watts GF; Abifadel M; Aguilar-Salinas CA; Akram A; Alnouri F; Alonso R; Al-Rasadi K; Banach M; Bogsrud MP; Bourbon M; Bruckert E; Car J; Corral P; Descamps O; Dieplinger H; Durst R; Freiberger T; Gaspar IM; Genest J; Harada-Shiba M; Jiang L; Kayikcioglu M; Lam CS; Latkovskis G; Laufs U; Liberopoulos E; Nilsson L; Nordestgaard BG; O'Donoghue JM; Sahebkar A; Schunkert H; Shehab A; Stoll M; Su TC; Susekov A; Widén E; Catapano AL; Ray KK
    Atherosclerosis; 2015 Nov; 243(1):257-9. PubMed ID: 26408930
    [No Abstract]   [Full Text] [Related]  

  • 14. Mutational analysis in UK patients with a clinical diagnosis of familial hypercholesterolaemia: relationship with plasma lipid traits, heart disease risk and utility in relative tracing.
    Humphries SE; Cranston T; Allen M; Middleton-Price H; Fernandez MC; Senior V; Hawe E; Iversen A; Wray R; Crook MA; Wierzbicki AS
    J Mol Med (Berl); 2006 Mar; 84(3):203-14. PubMed ID: 16389549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of SSCP and DHPLC for the detection of LDLR mutations in a New Zealand cohort.
    Bunn CF; Lintott CJ; Scott RS; George PM
    Hum Mutat; 2002 Mar; 19(3):311. PubMed ID: 11857755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiplex ARMS analysis to detect 13 common mutations in familial hypercholesterolaemia.
    Taylor A; Tabrah S; Wang D; Sozen M; Duxbury N; Whittall R; Humphries SE; Norbury G
    Clin Genet; 2007 Jun; 71(6):561-8. PubMed ID: 17539906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic mutation screening for the low-density lipoprotein receptor.
    Luft FC
    J Mol Med (Berl); 2006 Mar; 84(3):183-4. PubMed ID: 16482443
    [No Abstract]   [Full Text] [Related]  

  • 18. The LDLR variant T705I does not cause the typical phenotype of familial hypercholesterolaemia.
    Graham CA; Wright WT; McIlhatton BP; Young IS; Nicholls DP
    Atherosclerosis; 2006 Sep; 188(1):218-9. PubMed ID: 16735037
    [No Abstract]   [Full Text] [Related]  

  • 19. [Application of gene technology in the diagnosis of familial hypercholesterolemia].
    Leren TP; Bakken KS; Rødningen OK; Gundersen KE; Sundvold H; Berg K; Tonstad S; Ose L
    Tidsskr Nor Laegeforen; 1997 Feb; 117(5):678-81. PubMed ID: 9102960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Cardiovascular Risk in Heterozygous Familial Hypercholesterolemia Relatives Identified by Cascade Screening.
    Kjærgaard KA; Christiansen MK; Schmidt M; Olsen MS; Jensen HK
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28652386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.